Best Vascular, Inc.

Late-stage venture capital deals are on the rise. Four VCs explain how and why they invest here. by Mary Stuart In recent years, venture capitalists who once only invested in biotech have been increas

Cardiac stem cell therapy for regenerating diseased heart tissue has been long on promise but short on delivery. The unique combination of a Belgian incubator and start-up hope to finally bring this t

AMD is a multi-billion dollar market and the ultimate convergence opportunity, where devices complement—and even enable—pharmaceuticals. By Mary Stuart Ophthalmology has traditionally been an industry

A start-up founded by an engineer with no medical experience using technology from other industries is re-designing stents into true drug delivery vehicles. By Stephen Levin Innovation in medical devi